from San Francisco Business Times by Ron Leuty Guardant Health Inc. snagged nearly $100 million in funding from OrbiMed Advisors and others to aggressively expand its commercial and scientific work as competitors jump into the liquid biopsy market. The Redwood ...
Read More »